Drug Type Small molecule drug |
Synonyms L-701324 |
Action antagonists |
Mechanism GlyR antagonists(Glycine receptor antagonists), NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists), mGluRs antagonists(Metabotropic glutamate receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H14ClNO3 |
InChIKeyFLVRDMUHUXVRET-UHFFFAOYSA-N |
CAS Registry142326-59-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Ischemia | Preclinical | United Kingdom | 20 Feb 1999 | |
Epilepsy | Discovery | United States | - | |
Psychotic Disorders | Discovery | United States | - |